Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromisedOctober 31, 2022COVID-19 UpdatesVaccinesInfectious DiseasesRheumatologyOncology
Ten-day methotrexate pause after COVID vaccine booster enhances immunity against Omicron variantOctober 20, 2022COVID-19 UpdatesRheumatologyVaccines
Evusheld PrEP may protect immunocompromised patients from severe COVID-19October 7, 2022COVID-19 UpdatesRheumatologyInfectious DiseasesImmunology
Breakthrough COVID studies lend support to use of new boosters in immunosuppressed patientsOctober 4, 2022COVID-19 UpdatesRheumatologyDermatologyGastroenterologyVaccines
Severe COVID-19–related outcomes found worse in men with RASeptember 30, 2022COVID-19 UpdatesInfectious DiseasesRheumatology
New ESC guidelines for cutting CV risk in noncardiac surgerySeptember 15, 2022Musculoskeletal DisordersNeurologyOncologyPainRheumatologyPreventive CarePulmonology
Hip fractures likely to double by 2050 as population agesSeptember 13, 2022EndocrinologyRheumatologyGeriatrics
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depthAugust 29, 2022COVID-19 UpdatesVaccinesGastroenterologyRheumatologyInfectious DiseasesDermatology
Rivaroxaban outmatched by VKAs for AFib in rheumatic heart diseaseAugust 28, 2022CardiologyRheumatology
Vitamin D supplements do not lower risk of fracturesJuly 28, 2022Preventive CareRheumatologyMusculoskeletal Disorders
Methotrexate’s impact on COVID-19 vaccination: New insights madeJuly 19, 2022COVID-19 UpdatesRheumatologyDermatologyVaccines
Add AFib to noncardiac surgery risk evaluation: New supportJune 24, 2022CardiologyNeurologyOncologyRheumatologyVascular
Immunosuppressed rheumatic patients not at high risk of breakthrough COVID-19June 7, 2022COVID-19 UpdatesRheumatology
